COVID-19 Impact on Rheumatic Patients
Impact of COVID-19 Pandemic on Attitude, Behaviour and Mental Health of Patients With Rheumatic Diseases
1 other identifier
observational
360
1 country
1
Brief Summary
A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2020
CompletedFirst Submitted
Initial submission to the registry
May 23, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedJuly 15, 2020
July 1, 2020
20 days
May 23, 2020
July 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Score of five-item Brief Symptom Rating Scale (BSRS-5)
7\. Six questions for mental health assessment for patients and controls: Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5) which was derived from the 50-item BSRS
3 weeks
Study Arms (2)
1
180 patients diagnosed with autoimmune rheumatic disease. Patients are RA SLE Rhupus AS Behcet Sjogren Vasculitis FM Polymyalgia APA Sarcoidosis IBD Scleroderma DM PSA Mixed
2
control group composed of 180 healthy individuals (matched for age and sex)
Interventions
It was designed as a self-administered questionnaire with closed questions (yes/no questions, rating scale and multiple choice questions) and some open ended questions.
Eligibility Criteria
a total of 360 participants were included in this study and divided into two groups: cases group composed of 180 patients with rheumatic diseases and control group composed of 180 healthy individuals
You may qualify if:
- adult patient with diagnosed rheumatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Zagazig Universitycollaborator
Study Sites (1)
Kasr Alainy Hospital
Cairo, Non-US/Non-Canadian, 15551, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mervat Eissa
Cairo University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prpfessor
Study Record Dates
First Submitted
May 23, 2020
First Posted
May 29, 2020
Study Start
April 20, 2020
Primary Completion
May 10, 2020
Study Completion
May 20, 2020
Last Updated
July 15, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share